SARS-CoV-2 infection, myelin, and cognition in middle-aged and older adults: The CLSA COVID-19 Brain Health Study

Clicks: 2
ID: 340354
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #212 of 215 articles by views in Brain communications

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 215 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of COVID-19, has been hypothesized to contribute to cognitive decline through effects on myelin. We investigated SARS-CoV-2 infection effects on myelin and cognition in middle-aged and older adults. We analyzed cross-sectional MRI and cognitive data from the Canadian Longitudinal Study on Aging COVID-19 Brain Health Study. We quantified cerebral white matter myelin using myelin water imaging. Cognition included modified Rey Auditory Verbal Learning Test, Mental Alternation Test, and verbal fluency via animal fluency. Analysis of covariance were perfomed to determine differences between SARS-CoV-2 cases and controls adjusting for relevant confounding factors. Exploratory moderation analyses assessed the influence of biological sex, APOE ε4 status, and COVID-19-related symptom incidence and severity. We included 352 community-dwelling individuals with infection status determined at time of MRI scanning (SARS-CoV-2 cases, n = 64; controls, n = 288). Participant mean (SD) age was 65.3 (8.4) years, and 50.3% were female. There were no differences between SARS-CoV-2 cases and controls in myelin content or objective measures of cognition. There were no moderating effects of sex or APOE ε4 status. Cases showed greater incidence (P<0.001) and severity (P<0.001) of COVID-19-related symptoms. Moderation analysis of myelin content revealed significant interactions between symptom incidence and severity with diagnosis group after correcting for multiple comparisons (P corrected < 0.05). Post hoc analysis showed that symptom incidence and severity were inversely associated with myelin content in SARS-CoV-2 cases but not in controls across multiple regions-of-interest. SARS-CoV-2 cases and controls did not differ in myelin content or cognition. Among cases, greater self-reported symptom incidence and severity were associated with lower myelin content, an exploratory finding that requires longitudinal confirmation before it can be interpreted as infection-related myelin loss.
Reference Key
openalex_W7234764171 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Brain communications
Year 2026
DOI
10.1093/braincomms/fcag438
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.